221 related articles for article (PubMed ID: 10193663)
21. Migraine pharmacotherapy with oral triptans: a rational approach to clinical management.
Millson DS; Tepper SJ; Rapoport AM
Expert Opin Pharmacother; 2000 Mar; 1(3):391-404. PubMed ID: 11249525
[TBL] [Abstract][Full Text] [Related]
22. L-694,247: a potent 5-HT1D receptor agonist.
Beer MS; Stanton JA; Bevan Y; Heald A; Reeve AJ; Street LJ; Matassa VG; Hargreaves RJ; Middlemiss DN
Br J Pharmacol; 1993 Nov; 110(3):1196-200. PubMed ID: 8298808
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.
Pagniez F; Valentin JP; Vieu S; Colpaert FC; John GW
Br J Pharmacol; 1998 Jan; 123(2):205-14. PubMed ID: 9489607
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the human basilar artery contractile response to 5-HT and triptans.
Silva SA; Marques FB; Fontes Ribeiro CA
Fundam Clin Pharmacol; 2007 Jun; 21(3):265-72. PubMed ID: 17521295
[TBL] [Abstract][Full Text] [Related]
25. Eletriptan Pfizer.
Strijbos PJ; Parsons AA; Fugelli A
Curr Opin Investig Drugs; 2002 Sep; 3(9):1359-68. PubMed ID: 12498013
[TBL] [Abstract][Full Text] [Related]
26. Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation.
Razzaque Z; Heald MA; Pickard JD; Maskell L; Beer MS; Hill RG; Longmore J
Br J Clin Pharmacol; 1999 Jan; 47(1):75-82. PubMed ID: 10073743
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.
Pauwels PJ; Palmier C; Wurch T; Colpaert FC
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jan; 353(2):144-56. PubMed ID: 8717154
[TBL] [Abstract][Full Text] [Related]
28. Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry.
Nilsson T; Longmore J; Shaw D; Olesen IJ; Edvinsson L
Br J Pharmacol; 1999 Nov; 128(6):1133-40. PubMed ID: 10578124
[TBL] [Abstract][Full Text] [Related]
29. Activation of recombinant h 5-HT1B and h 5-HT1D receptors stably expressed in C6 glioma cells produces increases in Ca2+-dependent K+ current.
Le Grand B; Panissié A; Pauwels PJ; John GW
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):608-15. PubMed ID: 9879718
[TBL] [Abstract][Full Text] [Related]
30. Zolmitriptan-induced growth hormone release in humans: mediation by 5-HT1D receptors?
Whale R; Bhagwagar Z; Cowen PJ
Psychopharmacology (Berl); 1999 Jul; 145(2):223-6. PubMed ID: 10463324
[TBL] [Abstract][Full Text] [Related]
31. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
Ellwood AJ; Curtis MJ
Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
[TBL] [Abstract][Full Text] [Related]
32. Sumatriptan (GR 43175) interacts selectively with 5-HT1B and 5-HT1D binding sites.
Peroutka SJ; McCarthy BG
Eur J Pharmacol; 1989 Apr; 163(1):133-6. PubMed ID: 2545459
[TBL] [Abstract][Full Text] [Related]
33. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.
Edvinsson L; Uddman E; Wackenfors A; Davenport A; Longmore J; Malmsjö M
Clin Sci (Lond); 2005 Sep; 109(3):335-42. PubMed ID: 15853772
[TBL] [Abstract][Full Text] [Related]
34. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
Tfelt-Hansen P; De Vries P; Saxena PR
Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
[TBL] [Abstract][Full Text] [Related]
35. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
[TBL] [Abstract][Full Text] [Related]
36. Eletriptan.
Sandrini G; Perrotta A; Tassorelli C; Nappi G
Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1587-98. PubMed ID: 19929447
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of action of the 5-HT1B/1D receptor agonists.
Tepper SJ; Rapoport AM; Sheftell FD
Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
[TBL] [Abstract][Full Text] [Related]
38. The role of the 5-HT1D receptor as a presynaptic autoreceptor in the guinea pig.
Pullar IA; Boot JR; Broadmore RJ; Eyre TA; Cooper J; Sanger GJ; Wedley S; Mitchell SN
Eur J Pharmacol; 2004 Jun; 493(1-3):85-93. PubMed ID: 15189767
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
Omote M
Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
[TBL] [Abstract][Full Text] [Related]
40. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
